Meetings/Workshops on Oncology in China
Submit a meeting
Select a location:
Argentina (1) - Austria (1) - Belgium (1) - Bulgaria (1) - China (2) - Croatia (1) - Czech Republic (1) - France (2) - Germany (8) - Ghana (1) - India (2) - Italy (4) - Japan (1) - Malaysia (1) - Mexico (1) - Netherlands (1) - Portugal (1) - Singapore (1) - South Korea (1) - Switzerland (1) - United Kingdom (11) - United States (18) - ALL COUNTRIES (62)
Gordon Research Conference — Translational Cancer Genomics
30 Jun 2019 - 05 Jul 2019 • Hong Kong, China
Keystone Symposia: Cancer Stem Cells - Advances in Biology and Clinical Translation
13 Oct 2019 - 17 Oct 2019 • Pok Fu Lam, Hong Kong, China
Preponderant experimental and clinical evidence has demonstrated that pervasive cancer cell heterogeneity in both phenotypic presentations and functional properties exists, such that a population of cancer cells with cardinal stem cell properties (i.e., cancer stem cells) pre-exists in untreated tumors and spatiotemporally evolves during tumor progression and therapeutic interventions. Recent studies have also revealed significant phenotypic and functional plasticity in cancer cells, regulated by both genetic networks and epigenetic mechanisms. Both cancer cell heterogeneity and plasticity constitute major barriers to efficient and durable clinical treatments. Ever since the revival of the cancer stem cell research field around the turn of the century, we have made great strides in identifying and elucidating the biology of cancer stem cells in virtually all tumor systems. Significant progress has also been made in understanding how cancer stem cells interact with the cellular constituents and soluble factors in the proinflammatory and immune-suppressive tumor microenvironment. Facilitated by an explosion of technical advances in recent years, especially single-cell RNA-seq, we are achieving an unprecedented appreciation of the complexity of the cellular heterogeneity of human tumors. Significantly, novel therapeutic strategies that target cancer stem cells and cancer cell heterogeneity and plasticity are rapidly progressing to the clinical arena. This conference is organized to recapitulate these recent advances in our understanding of cancer stem cell biology and, importantly, the clinical translation of targeting cancer stem cells.
Attendee Services; Phone: [970.262.1230]; Email: firstname.lastname@example.org
stem cells, cancer, regenerative medicine, development
View all listed conferences in China.
Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events.
Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!
Last updated: 15 April 2019